MUSCELLA, Antonella
 Distribuzione geografica
Continente #
EU - Europa 10.326
AS - Asia 7.627
NA - Nord America 7.551
SA - Sud America 1.280
AF - Africa 195
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 26.992
Nazione #
US - Stati Uniti d'America 7.283
SG - Singapore 3.437
IT - Italia 3.008
IE - Irlanda 2.532
RU - Federazione Russa 2.101
CN - Cina 1.369
HK - Hong Kong 1.107
BR - Brasile 1.056
VN - Vietnam 671
SE - Svezia 667
UA - Ucraina 528
DE - Germania 444
IN - India 339
FI - Finlandia 260
FR - Francia 259
GB - Regno Unito 183
KR - Corea 148
CA - Canada 146
BD - Bangladesh 123
AR - Argentina 92
MX - Messico 90
JP - Giappone 84
ZA - Sudafrica 70
PL - Polonia 63
IQ - Iraq 61
PK - Pakistan 50
ES - Italia 43
SN - Senegal 43
NL - Olanda 42
EC - Ecuador 40
BE - Belgio 39
TR - Turchia 39
ID - Indonesia 37
LT - Lituania 32
CZ - Repubblica Ceca 30
IR - Iran 29
AT - Austria 22
AE - Emirati Arabi Uniti 18
VE - Venezuela 18
CL - Cile 17
MA - Marocco 16
TN - Tunisia 16
UZ - Uzbekistan 16
CO - Colombia 15
EG - Egitto 14
PY - Paraguay 14
PE - Perù 12
SA - Arabia Saudita 12
NP - Nepal 11
BG - Bulgaria 10
IL - Israele 10
MY - Malesia 10
CH - Svizzera 9
DZ - Algeria 9
JM - Giamaica 9
HU - Ungheria 8
KE - Kenya 8
BO - Bolivia 7
ET - Etiopia 7
JO - Giordania 7
RO - Romania 7
UY - Uruguay 7
AL - Albania 5
AZ - Azerbaigian 5
EU - Europa 5
LB - Libano 5
PS - Palestinian Territory 5
RS - Serbia 5
SY - Repubblica araba siriana 5
AU - Australia 4
BA - Bosnia-Erzegovina 4
GR - Grecia 4
GT - Guatemala 4
MD - Moldavia 4
PT - Portogallo 4
TW - Taiwan 4
AM - Armenia 3
BH - Bahrain 3
CR - Costa Rica 3
KW - Kuwait 3
KZ - Kazakistan 3
PH - Filippine 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
AO - Angola 2
BB - Barbados 2
BW - Botswana 2
BY - Bielorussia 2
BZ - Belize 2
CG - Congo 2
CI - Costa d'Avorio 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
LV - Lettonia 2
MU - Mauritius 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
Totale 26.973
Città #
Dublin 2.527
Lecce 2.464
Singapore 1.235
Hong Kong 1.032
San Jose 1.005
Ashburn 681
Moscow 652
Chandler 511
Dallas 481
Beijing 336
New York 289
Jacksonville 287
Council Bluffs 248
Ho Chi Minh City 240
Los Angeles 202
Wayanad 189
Lauterbourg 168
Hanoi 164
Princeton 161
Munich 157
Santa Clara 156
Seoul 142
São Paulo 126
Frankfurt am Main 99
Des Moines 98
Orem 86
Helsinki 79
Tokyo 78
Brooklyn 67
Bari 63
Montreal 62
Wilmington 58
Chennai 57
West Jordan 55
Ogden 54
Denver 52
Atlanta 51
London 51
Ann Arbor 50
Central District 50
Warsaw 50
Chicago 48
Lequile 44
Mexico City 44
Dakar 43
Johannesburg 42
Phoenix 42
Stockholm 42
Poplar 41
Rio de Janeiro 39
Rome 38
Brussels 36
Da Nang 35
Seelze 34
Toronto 33
Boston 32
Houston 31
Haiphong 30
Copertino 27
Kent 27
Manchester 26
San Francisco 26
San Pietro Vernotico 26
Baghdad 25
Falkenstein 25
Milan 25
Turku 25
Seattle 24
The Dalles 24
Jinan 23
Columbus 22
Lappeenranta 22
Ankara 21
Brno 21
Falls Church 21
Guangzhou 21
Nuremberg 21
Amsterdam 19
Boardman 19
Augusta 18
Bremen 17
Mumbai 17
San Mateo 17
Tianjin 17
Lahore 16
Querétaro 16
Belo Horizonte 15
Curitiba 15
Shanghai 15
St Louis 15
Zhengzhou 15
Aradeo 14
Biên Hòa 14
Guayaquil 14
Porto Alegre 14
Tashkent 14
Brasília 13
Goiânia 13
Guarulhos 13
Naples 13
Totale 16.072
Nome #
Exchequer motor game enhances geometric thinking and mood in first grade children 251
A monoclonal antibody to mammalian Angiotensin II AT1 receptor recognises one of the Angiotensin II receptor isoforms expressed by the eels. 250
INJURY PREVENTION IN YOUNG SOCCER PLAYERS: RESULTS OF A PILOT STUDY 249
Evaluation of the Antitumor Effects of Platinum-Based [Pt(η1-C2H4-OR)(DMSO)(phen)]+ (R = Me, Et) Cationic Organometallic Complexes on Chemoresistant Pancreatic Cancer Cell Lines 244
[Pt(O,O'-acac)(gamma-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway 240
ADP sensitizes ZL55 cells to the activity of cisplatin 238
[Pt(O,O'-acac)(γ-acac)(DMS)] induces autophagy and apoptosis in Skov-3 ovarian carcinoma cells 238
A new platinum(II) complex with high cytotoxicity in human endometrial cancer HeLa cells. 237
[Pt(O,O′-acac)(γ-acac)(DMS)] inhibits malignant pleural mesothelioma cells in vitro and in vivo 235
Inhibition of ZL55 cell proliferation by ADP via PKC-dependent signalling pathway 233
[Pt(O,O'-acac)(γ-acac)(DMS)] Induces Autophagy in Caki-1 Renal Cancer Cells 230
A new platinum(II) complex with high cytotoxicity in human breast cancer MCF-7 cells. 227
[Pt(O,O’-acac)(γ-acac)(DMS)] affects the intracellular Ca2+ homeostasis in MCF-7 breast cancer cells 224
Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma 223
[Pt(O,O’-acac)(γ-acac)(DMS)] exerts high and fast cytotoxicity in breast cancer cells in primary culture 220
A new platinum(II) complex with high cytotoxicity in human breast cancer MCF-7 cells 220
A new platinum (II) complex exerts higher cytotoxicity in tumoral than in normal human breast cells in primary culture. 219
[Pt(O,O'-acac)(gamma-acac)(DMS)] alters the expression of genes for cell cycle regulation and invasive function 219
A new platinum(II) complex with high cytotoxicity in normal and tumoural thyroid cell lines 218
Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells 212
ADP sensitizes ZL55 cells to the activity of anticancer cisplatin 212
[Pt(O,O’-acac)(γ-acac)(DMS)]: in vivo Studies of a Promising Anticancer Drug in Cancer Therapy 212
Antitumor and Antiangiogenic Activities of [Pt(O,O' acac)(γ-acac)(DMS)] in human renal cell carcinoma 208
[Pt(O,O'-acac)(γ-acac)(DMS)] alters SH-SY5Y cell migration and invasion by the inhibition of Na+/H+ exchanger isoform 1 occurring through a PKC-ε/ERK/mTOR Pathway. 205
In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma 204
[Pt(O,O’-acac)(γ-acac)(DMS)]: a comparative study with cisplatin in vivo. 203
Antitumor and antimigration effects of a new Pt compound on neuroblastoma cells 201
PKC-δ/PKC-α activity balance regulates the lethal effects of cisplatin 201
1H-NMR metabolomic study of SKOV-3 cells, response to the [Pt(O,O′-acac)(γ-acac)(DMS)] treatment 200
[Pt(O,O’-acac)(γ-acac)(DMS)] inhibits adhesion and migration of breast cancer cells 194
Cytotoxicity of new organometallic Pt(II)-complexes containing 1,10-phenantroline 194
Referees' physical performance over a soccer season 193
Activation of P2Y2 purinoceptor inhibits the activity of the Na+/K+ATPase in HeLa cells 192
Antitumor activity of [Pt(O,O’-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer 192
Response of cisplatin resistant SkOV-3 cells to [PT(O,O'-Acac)(γ-Acac)(DMS)] Treatment revealed by a metabolomic 1H-NMR study 190
An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects 189
Antitumor and antimigration effects of Salvia clandestina L. extract on osteosarcoma cells 187
Different apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary culture. 185
[Pt(O,O′-acac)(γ-acac)(DMS)] inhibits migration of tumor human breast cells in primary cultures 185
Cisplatin-analogous β-diketonate Pt(II) organometallic species: reactivity and cytotoxicity 184
Angiotensin II stimulates the Na+/H+ exchanger in human umbilical vein endothelial cells via AT1 receptor 183
The effects of exercise training on lipid metabolism and coronary heart disease 183
Antitumor Effects Induced by the Promising Drug [Pt(O,O′-acac)(γ-acac)(DMS)] in Cisplatin Resistant Epithelial Ovarian Carcinoma Cell Line (SKOV-3): a 1H NMR Metabolomic Study 181
Activation of P2Y2 receptor induces C-Fos protein through a pathway Involving Mitogen-Activated Protein Kinase and phosphoinositide 3-kinases in HeLa cells. 180
A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells 179
Differential functions of PKC-delta and PKC-zeta in cisplatin response of normal and transformed thyroid cells. 179
Activation of angiotensin II type I receptor promotes protein kinase C translocation and cell proliferation in human cultured breast epithelial cells 177
[Pt(O,O’-acac)(γ-acac)(DMS)] induces apoptosis in human breast cancer cells in primary culture 177
Cisplatin activates the PKC/ERK1/2 intracellular transduction pathways in rat thyroid PC Cl3 cells 176
Transbulbar B-Mode Sonography in Multiple Sclerosis: Clinical and Biological Relevance 171
Differential response of normal, dedifferentiated and transformed thyroid cell lines to cisplatin treatment 169
Is mitochondrial DNA profiling predictive for athletic performance? 169
Angiotensin II stimulation of the basolateral located Na/H antiporter in eel (Anguilla anguilla) enterocytes 168
Cytotoxicity of [Pt(O,O’-acac)(γ-acac)(DMS)] in normal and cancerous human breast cells in primary culture 168
The effects of training on hormonal concentrations in young soccer players 168
Bradykinin stimulates prostaglandin E2 release in human skeletal muscular fibroblasts 166
Different regulation of matrix metalloproteinase-2 in cisplatin response of normal and transformed thyroid cells 163
The Angiosuppressive Effects of [Pt(O,O′-acac)(γ-acac)(DMS)] 161
NMR-based metabolomic analyses of cisplatin resistant SKOV-3 cell line response to [Pt (O,O′-acac)(γ-acac)(DMS)], Ptac2S, treatment: comparison to cisplatin 161
NEW B-DIKETONATE PT(II) ORGANOMETALLIC SPECIES EXHIBITING HIGHER CYTOTOXIC ACTIVITY ON CANCER CELLS THAN CISPLATIN. 160
Immunolocalization of the AT-1R Ang II Receptor in Human Kidney Cancer 159
Protein kinase C-delta mediates cisplatin-induced apoptosis of ZL55 mesothelioma cells 159
Mitochondria-mediated apoptosis by a new Pt(II) compound, [Pt(O,O’-acac)(g-acac) (DMS)], in human breast cancer cells 158
Synthesis and characterization of new water-soluble organometallic complexes of the type [PtL(h1-C2H4OMe)(N^N)] (L = NH3, DMSO; N^N = dinitrogen ligand) with potential antitumor activity 158
Multiple isoforms of the oestrogen receptor in endometrial cancer 157
Adenosine diphosphate regulates MMP2 and MMP9 activity in malignant mesothelioma cells 157
Cytotoxic Activity of New β-Diketonate Platinum(II) Complexes on Cancer Cells 156
A novel monoclonal antibody to a plasmamembrane-located breast cancer antigen Interferes with the proliferation rate of cancerous cells in vitro 156
Purinergic receptors in a pleural mesotelioma cell line. 156
Dopamine and antioxidant grape seed extract loaded chitosan nanoparticles: A preliminary in vitro characterization. 154
AT1 angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinoma 153
Immunolocalisation of angiotensin II receptors in icefish (Chionodraco hamatus) tissues. 153
CCL20 promotes migration and invasiveness of human cancerous breast epithelial cells in primary culture 153
Effect of tumour size on the association between pS2 and cathepsin D in primary breast cancer 151
Angiotensin II AT1 Receptor Stimulates Na+/K+ATPase Activity Through a Pathway Involving PKC-z in Rat Thyroid Cells. 151
A new platinum(II) compound anticancer drug candidate with selective cytotoxicity for breast cancer cells 151
Involvement of Protein Kinase Cdelta and -epsilon in cisplatin-induced apoptosis in thyroid cells. 150
PKC-zeta is required for angiotensin II-induced activation of ERK and synthesis of C-FOS in MCF-7 cells 150
Synthesis, characterization and cytotoxic activity of novel Pt(II) complexes with acetylacetonate and amines 150
Synthesis and comparative evaluation of the cytotoxic activity of cationic organometallic complexes of the type [Pt(η1-CH2-CH2-OR)(DMSO)(phen)]+ (R = Me, Et, Pr, Bu) 148
Monitoring Psychometric States of Recovery to Improve Performance in Soccer Players: A Brief Review 146
EGFR MEDIATES THE CYTOTOXICITY OF CISPLATIN IN THE DIFFERENTIATED RAT THYROID PC CL3 CELL LINE THROUGH THE ACTIVATION OF MAPK/P38 145
PKC-epsilon-dependent cytosol-to-membrane translocation of pendrin in rat thyroid PC Cl3 cells. 143
Differential activation of ERK1/2 in human breast cancer MCF-7 cells treated with cisplatin or [Pt(O,O’-acac)(γ-acac)(DMS)] 142
ERK activation in cisplatin response in thyroid cell lines 142
Increase of [Ca2+]i via activation of ATP receptors in PC-Cl3 rat thyroid cell line 142
Angiotensin II modulates the activity of Na+/K+ATPase in cultured rat astrocytes via the AT1 receptor and protein kinase C-delta activation 141
In vivo study on xenograft model: [Pt(O,O’-acac)(γ-acac)(DMS)] versus cisplatin 141
Effects of extracellular nucleotides in the thyroid: P2Y(2) receptor-mediated ERK1/2 activation and c-Fos induction in PC Cl3 cells 140
Molecular Studies on Cisplatin Analogues 140
A Practical Approach to Assessing Physical Freshness: Utility of a Simple Perceived Physical Freshness Status Scale 139
Involvement of Protein Kinase C-delta and -epsylon in cisplatin-induced apoptosis in thyroid cells 139
Angiotensin II stimulation of Na+/K+ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells. 138
Cytotoxic activity in vitro of cisplatin and its analogous [Pt(acac)Cl(DMSO)]. 138
Different Cytotoxic Effects of Cisplatin on Pancreatic Ductal Adenocarcinoma Cell Lines 137
Transforming growth factor-β1 induces matrix metalloproteinase and cell migration in Schwann cells. 137
Efficacy of school-based intervention programs in reducing overweight: A randomized trial 136
CCL20 induces migration and proliferation on breast epithelial cells 136
Angiotensin II receptors in the gill of sea water- and freshwater-adapted eel 131
NOVEL B-DIKETONATE PT(II) COMPLEXES: A NEW PERSPECTIVE IN THE ANTICANCER METAL DRUG FIELD. 131
Totale 17.861
Categoria #
all - tutte 120.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.975


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021143 0 0 0 0 0 0 0 0 0 0 0 143
2021/2022802 14 4 54 78 109 12 22 49 21 64 118 257
2022/20234.325 192 334 173 132 156 268 29 189 2.681 14 98 59
2023/20241.581 132 91 107 92 133 158 22 58 221 307 173 87
2024/20255.122 98 29 109 80 342 558 180 249 1.679 538 477 783
2025/202611.806 1.086 1.413 1.024 1.550 1.243 570 1.365 534 1.615 811 438 157
Totale 27.363